bucillamine
Phase 2- Indications
- Long COVID, Nerve agent exposure, Rheumatoid arthritis
Company intelligence / Profile preview
Revive A Cell Therapeutics
Rancho Cucamonga, California, United Statesreviveacelltherapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Provides regenerative medicine services including stem cell therapies and exosome IV treatments for tissue repair and immune support. Focuses on outpatient procedures through a med spa model.
- Therapeutic areas
- PulmonologyEndocrinologyRheumatologyNeurology
- Modalities
- Stem cell therapyExosome IV therapy
- Industry
- Non-Academic Healthcare
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Revive A Cell Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Revive A Cell Therapeutics.